In a letter to Congress, the Chronic Care Policy Alliance (CCPA) expressed its opposition to H.R.3, the “Lower Drug Costs Now Act.” Read the full letter:
Dear Legislator,
I am writing on behalf of Chronic Care Policy Alliance to strongly oppose H.R. 3, the “Lower Drug Costs Now Act.” If passed, this misguided bill will be detrimental to the wellbeing of the patients with chronic diseases for which we advocate.
Chronic Care Policy Alliance (CCPA) is a network of state and regional advocacy organizations advancing public policy that improves the lives of those living with chronic conditions and diseases. Our organization represents the millions of Americans who are living with chronic illnesses, many of whom rely on access to prescription medications to maintain their health and quality of life.
In a letter sent to Congress on April 9, 2021, CCPA urged our elected officials to pursue policies that ensure accessible and affordable care for patients. As an organization, we strongly oppose policies such as H.R.3 that restrict the development of new drugs, or the research into cures for rare diseases, as they do not serve the needs of chronic disease patients in this country.
Should you have any questions about CCPA’s position, please feel free to follow up with me. I am available via phone and email.
Sincerely,
Liz Helms
Founding Director
Chronic Care Policy Alliance